iShares iBonds Dec 2030 Term Corporate ETF (IBDV) |
|
21.36 0 (0%)
|
06-26 18:57 |
|
Open: |
21.37 |
Pre. Close: |
21.36 |
|
High:
|
21.4824 |
Low:
|
21.36 |
|
Volume:
|
26,282 |
Market Cap:
|
0(M) |
|
|
|
|
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities. The underlying index consists of U.S. dollar-denominated, investment-grade securities issued by U.S. and non-U.S. corporate issuers that have $300 million or more of outstanding face value at the time of inclusion. It is non-diversified. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
21.51 - 21.63 |
21.63 - 21.74 |
|
Low:
|
21.09 - 21.23 |
21.23 - 21.35 |
|
Close:
|
21.16 - 21.38 |
21.38 - 21.58 |
|
Technical analysis |
as of: 2022-06-24 4:40:42 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 25.41 One year: 26.05 |
| Support: |
Support1: 20.86 Support2: 17.35 |
| Resistance: |
Resistance1: 21.75 Resistance2: 22.3 |
| Pivot: |
21.36  |
| Moving Average: |
MA(5): 21.27  MA(20): 21.52
MA(100): 22.56 MA(250): 24.17 |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 43.7 %D(3): 36 |
| RSI: |
RSI(14): 43 |
| 52-week: |
High: 26.25 Low: 20.86 |
| Average Vol(K): |
3-Month: 99 (K) 10-Days: 33 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IBDV ] has closed above bottom band by 49.3%. Bollinger Bands are 35.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 23 Mar 2022
Identification of Chicken CD44 as a Novel B Lymphocyte Receptor for Infectious Bursal Disease Virus | Journal of Virology - American Society for Microbiology
Tue, 01 Mar 2022
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality - Cureus
Wed, 16 Feb 2022
High mortality rates in IBDV explained - Poultry World
Wed, 09 Feb 2022
Birnaviridae Virus Factories Show Features of Liquid-Liquid Phase Separation and Are Distinct from Paracrystalline Arrays of Virions Observed by Electron Microscopy | Journal of Virology - American Society for Microbiology
Wed, 22 Sep 2021
Gumboro control in the field - Poultry World
Wed, 21 Jul 2021
Consistency and reliability of the IBD Immune-Complex Vaccine - The Poultry Site
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Technology |
| Industry: |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
